Class IIa HDACs - New insights into their functions in physiology and pathology

FEBS Journal

Volumn 282, Issue 9, 2015, Pages 1736-1744

  Parra, Maribel ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Cell differentiation; Class IIa HDACs; Development; HDAC4; HDAC5; HDAC7; HDAC9; Immune system; Metabolism; Neuronal physiology and pathology; Transcriptional repression

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE 9; MYOCYTE ENHANCER FACTOR 2; NUCLEAR RECEPTOR NUR77; POLO LIKE KINASE 3; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX2; HISTONE DEACETYLASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DEACETYLATION; ENERGY METABOLISM; GENE EXPRESSION; IMMUNE SYSTEM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; ENZYMOLOGY; HUMAN; METABOLISM; NERVE CELL;

ANIMALS; ENERGY METABOLISM; HISTONE DEACETYLASES; HUMANS; IMMUNE SYSTEM; MICE; NEURONS; OBESITY;

EID: 84928471452     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13061     Document Type: Article

References (52)

1. Parra M, &, Verdin E, (2010) Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol 10, 454-460.
2. Haberland M, Montgomery RL, &, Olson EN, (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10, 32-42.
3. Martin M, Kettmann R, &, Dequiedt F, (2009) Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol 53, 291-301.
4. Martin M, Kettmann R, &, Dequiedt F, (2007) Class IIa histone deacetylases: regulating the regulators. Oncogene 26, 5450-5467.
5. Allfrey VG, Faulkner R, &, Mirsky AE, (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51, 786-794.
6. Peng L, &, Seto E, (2011) Deacetylation of nonhistone proteins by HDACs and the implications in cancer. Handb Exp Pharmacol 206, 39-56.
7. Bannister AJ, &, Kouzarides T, (2011) Regulation of chromatin by histone modifications. Cell Res 21, 381-395.
8. Grozinger CM, Hassig CA, &, Schreiber SL, (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96, 4868-4873.
9. Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th'ng J, Han J, &, Yang XJ, (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19, 7816-7827.
10. Kao HY, Downes M, Ordentlich P, &, Evans RM, (2000) Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev 14, 55-66.
11. Mahlknecht U, Schnittger S, Ottmann OG, Schoch C, Mosebach M, Hiddemann W, &, Hoelzer D, (2000) Chromosomal organization and localization of the human histone deacetylase 5 gene (HDAC5). Biochim Biophys Acta 1493, 342-348.
12. Dequiedt F, Kasler H, Fischle W, Kiermer V, Weinstein M, Herndier BG, &, Verdin E, (2003) HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18, 687-698.
13. Fischle W, Dequiedt F, Fillion M, Hendzel MJ, Voelter W, &, Verdin E, (2001) Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem 276, 35826-35835.
14. Zhou X, Marks PA, Rifkind RA, &, Richon VM, (2001) Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci USA 98, 10572-10577.
15. Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, &, Kouzarides T, (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18, 5099-5107.
16. Lemercier C, Verdel A, Galloo B, Curtet S, Brocard MP, &, Khochbin S, (2000) mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem 275, 15594-15599.
17. McKinsey TA, Zhang CL, Lu J, &, Olson EN, (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111.
18. Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, &, Muscat GE, (2001) A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem 276, 17007-17013.
19. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, &, Verdin E, (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9, 45-57.
20. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, et al.,. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566.
21. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, &, Olson EN, (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488.
22. Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA, &, Olson EN, (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24, 8467-8476.
23. Chang S, Young BD, Li S, Qi X, Richardson JA, &, Olson EN, (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321-334.
24. Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN, &, D'Mello SR, (2008) HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Dev Neurobiol 68, 1076-1092.
25. Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET, Olson EN, &, Monteggia LM, (2012) An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 32, 10879-10886.
26. Sando R, Gounko N, Pieraut S, Liao L, Yates J, &, Maximov A, (2012) HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151, 821-834.
27. Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, Zondag S, Toriello HV, Magenis RE, &, Elsea SH, (2010) Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet 87, 219-228.
28. Morris B, Etoubleau C, Bourthoumieu S, Reynaud-Perrine S, Laroche C, Lebbar A, Yardin C, &, Elsea SH, (2012) Dose dependent expression of HDAC4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome. Am J Med Genet A 158A, 2015-2020.
29. Villavicencio-Lorini P, Klopocki E, Trimborn M, Koll R, Mundlos S, &, Horn D, (2013) Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4. Eur J Hum Genet 21, 743-748.
30. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, &, Herrup K, (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18, 783-790.
31. Mielcarek M, Landles C, Weiss A, Bradaia A, Seredenina T, Inuabasi L, Osborne GF, Wadel K, Touller C, Butler R, et al.,. (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol 11, e1001717.
32. Cho Y, &, Cavalli V, (2012) HDAC5 is a novel injury-regulated tubulin deacetylase controlling axon regeneration. EMBO J 31, 3063-3078.
33. Cho Y, Sloutsky R, Naegle KM, &, Cavalli V, (2013) Injury-induced HDAC5 nuclear export is essential for axon regeneration. Cell 155, 894-908.
34. Renthal W, Maze I, Krishnan V, Covington HE, Xiao G, Kumar A, Russo SJ, Graham A, Tsankova N, Kippin TE, et al.,. (2007) Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56, 517-529.
35. Taniguchi M, Carreira MB, Smith LN, Zirlin BC, Neve RL, &, Cowan CW, (2012) Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import. Neuron 73, 108-120.
36. Agis-Balboa RC, Pavelka Z, Kerimoglu C, &, Fischer A, (2013) Loss of HDAC5 impairs memory function: implications for Alzheimer's disease. J Alzheimers Dis 33, 35-44.
37. Sugo N, Oshiro H, Takemura M, Kobayashi T, Kohno Y, Uesaka N, Song WJ, &, Yamamoto N, (2010) Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci 31, 1521-1532.
38. Lang B, Alrahbeni TM, Clair DS, Blackwood DH, McCaig CD, &, Shen S, & the International Schizophrenia Consortium (2012) HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells. Am J Stem Cells 1, 31-41.
39. Kasler HG, &, Verdin E, (2007) Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol Cell Biol 27, 5184-5200.
40. Parra M, Kasler H, McKinsey TA, Olson EN, &, Verdin E, (2005) Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 280, 13762-13770.
41. Kasler HG, Young BD, Mottet D, Lim HW, Collins AM, Olson EN, &, Verdin E, (2011) Histone deacetylase 7 regulates cell survival and TCR signaling in CD4/CD8 double-positive thymocytes. J Immunol 186, 4782-4793.
42. Kasler HG, Lim HW, Mottet D, Collins AM, Lee IS, &, Verdin E, (2012) Nuclear export of histone deacetylase 7 during thymic selection is required for immune self-tolerance. EMBO J 31, 4453-4465.
43. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, et al.,. (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45, 670-675.
44. Navarro MN, Goebel J, Feijoo-Carnero C, Morrice N, &, Cantrell DA, (2011) Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nat Immunol 12, 352-361.
45. Barneda-Zahonero B, Román-González L, Collazo O, Rafati H, Islam AB, Bussmann LH, di Tullio A, De Andres L, Graf T, Lõpez-Bigas N, et al.,. (2013) HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet 9, e1003503.
46. de Zoeten EF, Wang L, Sai H, Dillmann WH, &, Hancock WW, (2010) Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583-594.
47. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, et al.,. (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13, 1299-1307.
48. Yan K, Cao Q, Reilly CM, Young NL, Garcia BA, &, Mishra N, (2011) Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem 286, 28833-28843.
49. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evans RM, Montminy M, &, Shaw RJ, (2011) Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607-621.
50. Wang B, Moya N, Niessen S, Hoover H, Mihaylova MM, Shaw RJ, Yates JR, Fischer WH, Thomas JB, &, Montminy M, (2011) A hormone-dependent module regulating energy balance. Cell 145, 596-606.
51. Chatterjee TK, Idelman G, Blanco V, Blomkalns AL, Piegore MG, Weintraub DS, Kumar S, Rajsheker S, Manka D, Rudich SM, et al.,. (2011) Histone deacetylase 9 is a negative regulator of adipogenic differentiation. J Biol Chem 286, 27836-27847.
52. Chatterjee TK, Basford JE, Knoll E, Tong WS, Blanco V, Blomkalns AL, Rudich S, Lentsch AB, Hui DY, &, Weintraub NL, (2014) HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding. Diabetes 63, 176-187.